Acetyl-L-Carnitine in the Treatment of Septic Shock
| Status: | Completed |
|---|---|
| Conditions: | Hospital, Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/10/2017 |
| Start Date: | August 2006 |
| End Date: | September 2009 |
Prospective, Randomized, Placebo-controlled, Double-Blinded, Phase II Pilot Study of Acetyl-L-carnitine in the Treatment of Patients With Septic Shock
This placebo-controlled study investigates acetyl-L-carnitine in the treatment of septic
shock requiring vasopressors.
shock requiring vasopressors.
This is a cross-over study which infuses ALC for 12 out of 18 hours (and placebo the other
6). Patients must have vasopressor-dependent septic shock and be free from renal failure,
hepatic failure, and seizures to be eligible.
6). Patients must have vasopressor-dependent septic shock and be free from renal failure,
hepatic failure, and seizures to be eligible.
Inclusion Criteria:
- documented or presumed infection
- shock requiring vasopressors
Exclusion Criteria:
- dialysis
- hepatic failure
- seizures
We found this trial at
1
site
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
